Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | STAT3 | P40763 | 1/20 | 0.60 |
| ▸ | NPC1 | O15118 | 7/20 | 0.51 |
| ▸ | RAB9A | P51151 | 6/20 | 0.51 |
| ▸ | MEN1 | O00255 | 6/20 | 0.51 |
| ▸ | KMT2A | Q03164 | 6/20 | 0.51 |
| ▸ | RXFP1 | Q9HBX9 | 1/20 | 0.51 |
| ▸ | P2RX1 | P51575 | 2/20 | 0.50 |
| ▸ | P2RX4 | Q99571 | 1/20 | 0.50 |
| ▸ | P2RX7 | Q99572 | 1/20 | 0.50 |
| ▸ | KDM4E | B2RXH2 | 4/20 | 0.48 |
| ▸ | TP53 | P04637 | 3/20 | 0.48 |
| ▸ | HTT | P42858 | 3/20 | 0.48 |
| ▸ | HPGD | P15428 | 3/20 | 0.48 |
| ▸ | GAA | P10253 | 2/20 | 0.48 |
| ▸ | HSD17B10 | Q99714 | 2/20 | 0.48 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.48 |
| ▸ | RCE1 | Q9Y256 | 1/20 | 0.48 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.48 |
| ▸ | FFAR2 | O15552 | 2/20 | 0.46 |
| ▸ | LMNA | P02545 | 2/20 | 0.45 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL30339207 | 0.85 | NPC1 (0.54) | STAT3NPC1RAB9AMEN1KMT2A | |
| SCHEMBL31665144 | 0.85 | RAB9A (0.51) | STAT3NPC1RAB9ARXFP1KDM4E | |
| SCHEMBL24073820 | 0.85 | NPC1 (0.54) | STAT3NPC1RAB9AMEN1KMT2A | |
| SCHEMBL30142719 | 0.82 | RXFP1 (0.52) | STAT3NPC1RAB9AMEN1KMT2A | |
| SCHEMBL28805498 | 0.82 | STAT3 (0.55) | STAT3NPC1RAB9AMEN1KMT2A | |
| SCHEMBL24074019 | 0.82 | RXFP1 (0.52) | STAT3NPC1RAB9AMEN1KMT2A | |
| SCHEMBL24823416 | 0.82 | KCNMA1 (0.57) | MEN1KMT2AP2RX1P2RX4P2RX7 | |
| SCHEMBL743401 | 0.80 | ALDH1A1 (0.64) | STAT3NPC1RAB9AMEN1KMT2A | |
| SCHEMBL16256828 | 0.79 | STAT3 (0.64) | STAT3NPC1RAB9AMEN1KMT2A | |
| SCHEMBL13836739 | 0.79 | STAT3 (0.64) | STAT3NPC1RAB9AMEN1KMT2A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 25 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-2429986-B1 | HALOALKYL HETEROARYL BENZAMIDE COMPOUNDS | ROMARK LAB LC (US) | 2016-11-16 | — | — | EP | claimed |
| US-RE47786-E1 | Haloalkyl heteroaryl benzamide compounds | ROMARK LABORATORIES L.C. (US) | 2019-12-31 | — | — | US | disclosed |
| US-RE47786-E1 | Haloalkyl heteroaryl benzamide compounds | ROMARK LABORATORIES L.C. (US) | 2019-12-31 | — | — | US | disclosed |
| US-RE46724-E1 | Haloalkyl heteroaryl benzamide compounds | ROMARK LABORATORIES, L.C. (US) | 2018-02-20 | — | — | US | disclosed |
| US-RE46724-E1 | Haloalkyl heteroaryl benzamide compounds | ROMARK LABORATORIES, L.C. (US) | 2018-02-20 | — | — | US | disclosed |
| US-RE46724-E1 | Haloalkyl heteroaryl benzamide compounds | ROMARK LABORATORIES, L.C. (US) | 2018-02-20 | — | — | US | disclosed |
| EP-2429986-B1 | HALOALKYL HETEROARYL BENZAMIDE COMPOUNDS | ROMARK LAB LC (US) | 2016-11-16 | — | — | EP | disclosed |
| EP-2429986-B1 | HALOALKYL HETEROARYL BENZAMIDE COMPOUNDS | ROMARK LAB LC (US) | 2016-11-16 | — | — | EP | disclosed |
| EP-3078377-A2 | NITAZOXANIDE AND TIZOXANIDE AS ANTI-VIRAL AGENTS | Romark Laboratories, L.C. (US) | 2016-10-12 | — | — | EP | disclosed |
| EP-3078377-A2 | NITAZOXANIDE AND TIZOXANIDE AS ANTI-VIRAL AGENTS | Romark Laboratories, L.C. (US) | 2016-10-12 | — | — | EP | disclosed |
| US-20140341850-A1 | HALOALKYL HETEROARYL BENZAMIDE COMPOUNDS | ROMARK LABORATORIES, L.C. (US) | 2014-11-20 | — | — | US | disclosed |
| US-8846727-B2 | Haloalkyl heteroaryl benzamide compounds | ROMARK LABORATORIES, L.C. (US) | 2014-09-30 | — | — | US | disclosed |
| US-8846727-B2 | Haloalkyl heteroaryl benzamide compounds | ROMARK LABORATORIES, L.C. (US) | 2014-09-30 | — | — | US | disclosed |
| US-8846727-B2 | Haloalkyl heteroaryl benzamide compounds | ROMARK LABORATORIES, L.C. (US) | 2014-09-30 | — | — | US | disclosed |
| EP-2429986-A1 | HALOALKYL HETEROARYL BENZAMIDE COMPOUNDS | Romark Laboratories, L.C. (US) | 2012-03-21 | — | — | EP | disclosed |
| US-20100292274-A1 | HALOALKYL HETEROARYL BENZAMIDE COMPOUNDS | ROMARK LABORATORIES L.C. | 2010-11-18 | — | — | US | disclosed |
| US-20100292274-A1 | HALOALKYL HETEROARYL BENZAMIDE COMPOUNDS | ROMARK LABORATORIES L.C. | 2010-11-18 | — | — | US | disclosed |
| US-20100292274-A1 | HALOALKYL HETEROARYL BENZAMIDE COMPOUNDS | ROMARK LABORATORIES L.C. | 2010-11-18 | — | — | US | disclosed |
| WO-2010132404-A1 | HALOALKYL HETEROARYL BENZAMIDE COMPOUNDS | ROMARK LABORATORIES L.C. (US) | 2010-11-18 | — | — | WO | disclosed |
| WO-2010132404-A1 | HALOALKYL HETEROARYL BENZAMIDE COMPOUNDS | ROMARK LABORATORIES L.C. (US) | 2010-11-18 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20100292274-A1 | HALOALKYL HETEROARYL BENZAMIDE COMPOUNDS | HDHD5, HAVCR2, AADAC | STAT3 4348/4885NPC1 338/4885RAB9A 1886/4885 |
| US-20140341850-A1 | HALOALKYL HETEROARYL BENZAMIDE COMPOUNDS | HDHD5, HAVCR2, AADAC | STAT3 4348/4885NPC1 338/4885RAB9A 1886/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.